Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

March 14, 2012

UNITED THERAPEUTICS CORPORATION v. SANDOZ, INC.

Track this case

Case Number:

3:12-cv-01617

Court:

New Jersey

Nature of Suit:

Patent

Judge:

Peter G. Sheridan

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. September 30, 2015

    Sandoz, UTC Settle Generic Remodulin Patent Suit

    United Therapeutics Corp. has given Sandoz Inc. a non-exclusive license to manufacture and sell a generic version of its hypertension drug Remodulin, ending more than three years of patent litigation, UTC announced Wednesday.

3 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login